🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To investigate safety, tolerability, the effects on cognition and brain met...
Status
Completed
Location
Pacific Research Network, Inc
Start Date
2021-07-22
Trial ID
NCT04381468
The purpose of the study is to evaluate the safety and tolerability of pepi...
Status
Completed
Location
Highlands Oncology Group, PA - North Hills
Start Date
2021-08-09
Trial ID
NCT04815720
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, PK, and ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-07
Trial ID
NCT02481674
This phase I trial studies how well anti-semaphorin 4D (SEMA4D) monoclonal ...
Status
Active Not Recruiting
Location
Emory University Hospital Midtown
Start Date
2018-11-01
Trial ID
NCT03690986
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of pepinemab a...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2018-01-31
Trial ID
NCT03320330
Treatments Being Tested
The purpose of this study is to test the safety of Adoptive T-Cell therapy ...
Status
Suspended
Location
Moffitt Cancer Center
Start Date
2022-05-31
Trial ID
NCT05378464
Treatments Being Tested
This trial will assess the safety and tolerability of Pepinemab in combinat...
Status
Active Not Recruiting
Location
University of Rochester Medical Center
Start Date
2022-12-10
Trial ID
NCT05102721
Treatments Being Tested
This pilot phase I trial studies how well VX15/2503 (pepinemab) with or wit...
Status
Active Not Recruiting
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2018-12-13
Trial ID
NCT03769155
Treatments Being Tested